Hemophilia

What the Oral and Maxillofacial Surgeon Needs to Know

Julie Smith

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Hemophilia will be encountered in the oral and maxillofacial surgeon's office. A thorough understanding of hemophilia is necessary to safely care for these patients. One must understand the severity of the patient's hemophilia as well as whether or not inhibitors are present. The patient's surgical management will be influenced by these two factors. In addition to the possible need to transfuse factors or desmopressin, special care must be taken perioperatively to avoid bleeding complications. This article reviews the overall management of hemophilia A and B as well as the specific perioperative management of these patients.

Original languageEnglish (US)
Pages (from-to)481-489
Number of pages9
JournalOral and Maxillofacial Surgery Clinics of North America
Volume28
Issue number4
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

Hemophilia A
Hemophilia B
Deamino Arginine Vasopressin
Patient Care
Hemorrhage
Oral and Maxillofacial Surgeons

Keywords

  • Bleeding disorders
  • Factor IX deficiency
  • Factor VIII bypass agents
  • Factor VIII deficiency
  • Hemophilia
  • Hemophilia inhibitors

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Cite this

Hemophilia : What the Oral and Maxillofacial Surgeon Needs to Know. / Smith, Julie.

In: Oral and Maxillofacial Surgery Clinics of North America, Vol. 28, No. 4, 01.11.2016, p. 481-489.

Research output: Contribution to journalReview article

@article{ed6edb1c7b394604b486b3fc2bf97491,
title = "Hemophilia: What the Oral and Maxillofacial Surgeon Needs to Know",
abstract = "Hemophilia will be encountered in the oral and maxillofacial surgeon's office. A thorough understanding of hemophilia is necessary to safely care for these patients. One must understand the severity of the patient's hemophilia as well as whether or not inhibitors are present. The patient's surgical management will be influenced by these two factors. In addition to the possible need to transfuse factors or desmopressin, special care must be taken perioperatively to avoid bleeding complications. This article reviews the overall management of hemophilia A and B as well as the specific perioperative management of these patients.",
keywords = "Bleeding disorders, Factor IX deficiency, Factor VIII bypass agents, Factor VIII deficiency, Hemophilia, Hemophilia inhibitors",
author = "Julie Smith",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.coms.2016.06.006",
language = "English (US)",
volume = "28",
pages = "481--489",
journal = "Oral and Maxillofacial Surgery Clinics of North America",
issn = "1042-3699",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Hemophilia

T2 - What the Oral and Maxillofacial Surgeon Needs to Know

AU - Smith, Julie

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Hemophilia will be encountered in the oral and maxillofacial surgeon's office. A thorough understanding of hemophilia is necessary to safely care for these patients. One must understand the severity of the patient's hemophilia as well as whether or not inhibitors are present. The patient's surgical management will be influenced by these two factors. In addition to the possible need to transfuse factors or desmopressin, special care must be taken perioperatively to avoid bleeding complications. This article reviews the overall management of hemophilia A and B as well as the specific perioperative management of these patients.

AB - Hemophilia will be encountered in the oral and maxillofacial surgeon's office. A thorough understanding of hemophilia is necessary to safely care for these patients. One must understand the severity of the patient's hemophilia as well as whether or not inhibitors are present. The patient's surgical management will be influenced by these two factors. In addition to the possible need to transfuse factors or desmopressin, special care must be taken perioperatively to avoid bleeding complications. This article reviews the overall management of hemophilia A and B as well as the specific perioperative management of these patients.

KW - Bleeding disorders

KW - Factor IX deficiency

KW - Factor VIII bypass agents

KW - Factor VIII deficiency

KW - Hemophilia

KW - Hemophilia inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84995503660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995503660&partnerID=8YFLogxK

U2 - 10.1016/j.coms.2016.06.006

DO - 10.1016/j.coms.2016.06.006

M3 - Review article

VL - 28

SP - 481

EP - 489

JO - Oral and Maxillofacial Surgery Clinics of North America

JF - Oral and Maxillofacial Surgery Clinics of North America

SN - 1042-3699

IS - 4

ER -